Dana Investment Advisors Inc. raised its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 45.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 279,954 shares of the medical instruments supplier’s stock after acquiring an additional 87,954 shares during the quarter. Dana Investment Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $3,553,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Mitsubishi UFJ Trust & Banking Corp grew its position in shares of DENTSPLY SIRONA by 1,836.7% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock valued at $1,344,000 after buying an additional 100,468 shares during the last quarter. Bank of Montreal Can boosted its stake in DENTSPLY SIRONA by 8.2% in the second quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after acquiring an additional 26,610 shares in the last quarter. Commonwealth Equity Services LLC grew its holdings in shares of DENTSPLY SIRONA by 38.4% during the third quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after purchasing an additional 223,339 shares during the last quarter. CWM LLC increased its position in shares of DENTSPLY SIRONA by 84.3% during the third quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock worth $5,336,000 after purchasing an additional 192,373 shares in the last quarter. Finally, Advisors Asset Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 42.8% in the 3rd quarter. Advisors Asset Management Inc. now owns 348,989 shares of the medical instruments supplier’s stock valued at $4,429,000 after purchasing an additional 104,588 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the company. Barclays began coverage on DENTSPLY SIRONA in a research note on Monday, December 8th. They set an “underweight” rating and a $12.00 price target on the stock. Mizuho increased their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a report on Tuesday, January 20th. Barrington Research reaffirmed an “outperform” rating and issued a $14.00 target price on shares of DENTSPLY SIRONA in a report on Monday, January 5th. Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Finally, Zacks Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $14.46.
Insider Activity
In related news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.52% of the stock is currently owned by company insiders.
DENTSPLY SIRONA Price Performance
Shares of NASDAQ XRAY opened at $13.14 on Wednesday. The stock has a fifty day moving average price of $12.29 and a 200 day moving average price of $12.47. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $19.27. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company has a market cap of $2.62 billion, a PE ratio of -2.97, a P/E/G ratio of 0.99 and a beta of 1.01.
DENTSPLY SIRONA Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. DENTSPLY SIRONA’s payout ratio is presently -14.48%.
DENTSPLY SIRONA Profile
Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.
The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
